Each vial contains 10 mg of research‑grade Tirzepatide.

Tirzepatide is a dual‑agonist peptide that engages GLP‑1 and GIP receptors, offering a versatile tool for investigators studying metabolic signaling pathways. This material is supplied for research purposes only and is not intended for human or veterinary use.